Skip to content

Pilot study with the OPTIGRIP

Pilot study with the Optigrip®: First clinical performance data and user experience - Pilot study with the Optigrip®: First clinical performance data and user experience

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON58521
Enrollment
40
Registered
2025-03-05
Start date
2026-06-19
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholecystolithiasis, colonpathology, morbide obesity and lung cancer gal stone illness, large bowel diseases, extreme overweight, cancer in the chest

Interventions

Optigrip

Sponsors

Ziekenhuis Groep Twente (ZGT)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients who have signed informed consent and are 18 years or older, undergoing one of the following elective (non-complex): A) Laparoscopic cholecystectomy for uncomplicated cholethiasis, B) Omega loop gastric bypass, C) Left sided colorectal surgery either for malignancy or diverticulitis D) Thoracic surgery, either for malignant or benign disease.

Exclusion criteria

Exclusion criteria: A potential participant who meets any of the following criteria will be excluded from participation in this study: • High risk of conversion to laparotomy due to earlier abdominal procedures • Pregnancy • Since the OPTIGRIP® trial is an interventional study, it is not considered desirable to combine this trial with other interventional studies.

Design outcomes

Primary

MeasureTime frame
1) Performance: Surgeon opinion on the performance of the Optigrip using closed questions regarding the following claims: a. Grasping, manipulation, preparation, dissection and clamping of tissue b. Feeling pulsating structures c. Feeling differences in tissue stiffness d. Reducing applied forces on the tissue 2) Safety: Device related adverse events 3) User experience: Surgeon feedback on the performance and clinical relevance of the Optigrip using open questions 

Secondary

MeasureTime frame
The force applied to the grasped tissue when using the Optigrip, both with the haptic feed-back feature ON and OFF, will be compared quantitatively.

Countries

Netherlands

Contacts

Public ContactJJ Harlaar

Ziekenhuis Groep Twente (ZGT)

joris.harlaar@gmail.com+31622127121

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026